US2021355529A1PendingUtilityA1

Polyphenolic additives in sequencing-by-synthesis

72
Assignee: ISOPLEXIS CORPPriority: Feb 11, 2016Filed: Jul 28, 2021Published: Nov 18, 2021
Est. expiryFeb 11, 2036(~9.6 yrs left)· nominal 20-yr term from priority
C12Q 1/6869C12Q 1/6823
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of incorporating labeled nucleotides, comprising:
 a) providing
 i) a plurality of nucleic acid primers and template molecules, 
 ii) a polymerase, 
 iii) a cleave reagent comprising a reducing agent and a polyphenolic compound, and 
 iv) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base; 
   b) hybridizing at least a portion of said primers to at least a portion of said template molecules so as to create hybridized primers;   c) incorporating a first labeled nucleotide analogue with said polymerase into at least a portion of said hybridized primers so as to create extended primers comprising an incorporated labeled nucleotide analogue;   d) detecting said incorporated labeled nucleotide analogue; and   e) cleaving the cleavable linker of said incorporated nucleotide analogues with said cleave reagent.   
     
     
         2 . The method of  claim 1 , wherein said polyphenolic compound is selected from the group consisting of gallic acid, gentisic acid, pryocatechol, pyrogallol, hydroquinone and resorcinol. 
     
     
         3 . The method of  claim 1 , wherein said reducing agent of said cleave reagent comprises TCEP (tris(2-carboxyethyl)phosphine). 
     
     
         4 . The method of  claim 1 , wherein said incorporated nucleotide analogues of step c) further comprise a removable chemical moiety capping the 3'-OH group. 
     
     
         5 . The method of  claim 3 , wherein the cleaving of step e) removes the removable chemical moiety capping the 3'-OH group. 
     
     
         6 . The method of  claim 5 , wherein the method further comprises:
 f) incorporating a second nucleotide analogue with said polymerase into at least a portion of said extended primers.   
     
     
         7 . The method of  claim 1 , wherein said label is fluorescent. 
     
     
         8 . A cleave reagent comprising i) a reducing agent, and ii) a polyphenolic compound. 
     
     
         9 . The cleave reagent of  claim 8 , wherein said polyphenolic compound is selected from the group consisting of gallic acid, gentisic acid, pryocatechol, pyrogallol, hydroquinone, and/or resorcinol. 
     
     
         10 . The cleave reagent of  claim 8 , wherein said reducing agent is TCEP Tris(2-carboxyethyl)phosphine). 
     
     
         11 . A kit, comprising i) the cleave reagent of  claim 8  and ii) a plurality of nucleotide analogues wherein at least a portion of said nucleotide analogues is labeled with a label attached through a cleavable disulfide linker to the base. 
     
     
         12 . A system comprising primers hybridized to template in solution, said solution comprising the cleave reagent of  claim 8 . 
     
     
         13 . The system of  claim 11 , wherein said hybridized primers and template are immobilized. 
     
     
         14 . The system of  claim 12 , wherein said hybridized primers and template are in a flow cell.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.